Research highlights

Training Network for Optimizing Adoptive T cell Therapy of Cancer (T-OP) The clinical implementation of immunotherapeutics has established T cells as efficient anti-cancer weapons if targeted by specific drugs.

Ongoing

Patient-centered innovation in plastic and reconstructive surgery This project aims to co-design and implement digital care pathways with customized patient education to properly involve and inform patients during their care process.

Ongoing

Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1) This study evaluates whether a nationwide program of best practices in pancreatic cancer care can improve 1-year overall survival and quality of life.

Ongoing

Patient-tailored Glucocorticoid Treatment to Prevent Bronchopulmonary Dysplasia and Enhance Neurodevelopmental Outcome in Very Preterm Infants An innovative prediction model for bronchopulmonary dysplasia based on pro-inflammatory and anti-inflammatory markers will facilitate decision-making for the treatment of very preterm infants

Evidence-based classification of vision impairment in Paralympic judo Research on the impact of vision impairment on judo performance and how judokas with vision impairment should be classified for Paralympic competition.

Ongoing

Shared decision making about palliative systemic treatment: CHOICE and SYMPHONY Addressing the effect of a variety of interventions to promote Shared Decision Making in consultations about treatment for advanced cancer.

Ongoing

Developing immunotherapy for atherosclerosis: a challenging adventure Immunotherapy is integrated in oncology treatment, but the exploitation in cardiovascular disease is in its infancy. Lowering inflammation is an important strategy for combating cardiovascular disease.

Ongoing

Targeting hepatic bile salt uptake to treat cholestasis or the metabolic syndrome AGEM In this project we aim to understand the role of bile acids (and its dynamics) in energy, fat and glucose homeostasis, and in inflammation.

Ongoing

Single domain antibody targeting of the CD1d monomorphic antigen-presenting molecule induces potent anti-tumour activity Camelid-derived single domain antibodies (VHH)5 specific for the human MHC class I-like molecule CD1d can modulate the function of CD1d-restricted T cell populations.

Ongoing

Our research highlights

Amsterdam UMC makes use of cookies